Read time: less than 1 minute
A lack of transparency across the pharmacy marketplace stems from a number of different factors. Ultimately, it impacts the patient experience and can create confusion.
Heightened transparency across the broader system could help support health systems’ ability to generate savings and revenue to support extending care to the uninsured and underinsured, which is key to extending pharmacy and patient care services.
Andrew Wilson, vice president, 340B Solutions for McKesson, shares three key considerations in understanding 340B program results and benefits. Read more from Drug Topics.
Share
Post
Post
Email